| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:17 UTC |
|---|
| Update Date | 2021-09-14 15:38:57 UTC |
|---|
| HMDB ID | HMDB0013870 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | cis,trans-5'-Hydroxythalidomide |
|---|
| Description | cis,trans-5'-Hydroxythalidomide, also known as 5'-OH-thalidomide, belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. cis,trans-5'-Hydroxythalidomide is an extremely weak basic (essentially neutral) compound (based on its pKa). |
|---|
| Structure | OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)NC1=O InChI=1S/C13H10N2O5/c16-9-5-8(10(17)14-11(9)18)15-12(19)6-3-1-2-4-7(6)13(15)20/h1-4,8-9,16H,5H2,(H,14,17,18) |
|---|
| Synonyms | | Value | Source |
|---|
| 5'-OH-Thalidomide | HMDB | | 5'-Hydroxythalidomide | MeSH |
|
|---|
| Chemical Formula | C13H10N2O5 |
|---|
| Average Molecular Weight | 274.2289 |
|---|
| Monoisotopic Molecular Weight | 274.05897144 |
|---|
| IUPAC Name | 2-(5-hydroxy-2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione |
|---|
| Traditional Name | 2-(5-hydroxy-2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)NC1=O |
|---|
| InChI Identifier | InChI=1S/C13H10N2O5/c16-9-5-8(10(17)14-11(9)18)15-12(19)6-3-1-2-4-7(6)13(15)20/h1-4,8-9,16H,5H2,(H,14,17,18) |
|---|
| InChI Key | HHTOWVWIVBSOKC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Isoindoles and derivatives |
|---|
| Sub Class | Isoindolines |
|---|
| Direct Parent | Phthalimides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phthalimide
- Alpha-amino acid or derivatives
- Isoindole
- Piperidinedione
- Delta-lactam
- Piperidinone
- Benzenoid
- Piperidine
- Carboxylic acid imide, n-substituted
- Carboxylic acid imide
- Dicarboximide
- Carboxylic acid imide, n-unsubstituted
- Lactam
- Secondary alcohol
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Alcohol
- Carbonyl group
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 3.98 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.5863 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.93 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1739.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 267.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 107.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 173.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 76.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 313.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 465.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 75.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 789.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 351.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1208.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 244.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 298.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 436.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 181.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 156.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| cis,trans-5'-Hydroxythalidomide,1TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)NC1=O | 2632.8 | Semi standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)C(O)CC(N2C(=O)C3=CC=CC=C3C2=O)C1=O | 2473.2 | Semi standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,2TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N([Si](C)(C)C)C1=O | 2501.8 | Semi standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,2TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N([Si](C)(C)C)C1=O | 2613.0 | Standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,2TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N([Si](C)(C)C)C1=O | 3362.2 | Standard polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)NC1=O | 2868.1 | Semi standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)C(O)CC(N2C(=O)C3=CC=CC=C3C2=O)C1=O | 2736.5 | Semi standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 2964.2 | Semi standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 3034.9 | Standard non polar | 33892256 | | cis,trans-5'-Hydroxythalidomide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N([Si](C)(C)C(C)(C)C)C1=O | 3447.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - cis,trans-5'-Hydroxythalidomide GC-MS (Non-derivatized) - 70eV, Positive | splash10-05fr-3960000000-0d3d37ff76fdfb87791e | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - cis,trans-5'-Hydroxythalidomide GC-MS (1 TMS) - 70eV, Positive | splash10-00di-4963000000-5c3650820ae538f05811 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - cis,trans-5'-Hydroxythalidomide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 10V, Positive-QTOF | splash10-004i-0090000000-079837f6d6cfe874a480 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 20V, Positive-QTOF | splash10-0kdi-0390000000-b2931b26f95e0d654ba2 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 40V, Positive-QTOF | splash10-05g1-7910000000-127e1af15d9ce6980642 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 10V, Negative-QTOF | splash10-00ec-3190000000-252159f1998f82fd39dc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 20V, Negative-QTOF | splash10-05fu-3590000000-daefbb2dfdeb1a8bc739 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 40V, Negative-QTOF | splash10-0007-9200000000-4897f0c5d2567b205009 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 10V, Negative-QTOF | splash10-00dj-0790000000-cf25d8d92906fb5756db | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 20V, Negative-QTOF | splash10-00dj-2980000000-2cd101c0bcf2b3350bb5 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 40V, Negative-QTOF | splash10-0002-3900000000-fb7da6edc3222a7defa5 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 10V, Positive-QTOF | splash10-004i-0190000000-60d396dd0f7677a62d71 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 20V, Positive-QTOF | splash10-004i-0690000000-76bf4597a518ab5a1539 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis,trans-5'-Hydroxythalidomide 40V, Positive-QTOF | splash10-0a4i-2900000000-fdf792b17831511bef06 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|